SEL-018

N/A

Report date: 2023/10/26 16:56:50

Base Information

Drug NameSEL-018
Drug Alias NameXorkIdeXorkSEL-018
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionImmunoglobulin G modulators
TargetsImmunoglobulin G
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncSelecta Biosciences Inc
Inactive CompaniesAudentes Therapeutics Inc
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A